What is the cause of an eczematoid rash at intertriginous areas in patients receiving prolonged Total Parenteral Nutrition (TPN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is (b) fatty acid deficiency, as eczematoid rash in intertriginous areas is a characteristic manifestation of essential fatty acid deficiency in patients receiving prolonged total parenteral nutrition (TPN) without adequate lipid supplementation 1. This condition typically develops after 2-4 weeks of fat-free TPN. The rash appears as scaly, erythematous patches in skin fold areas and can progress to generalized dermatitis if untreated. Essential fatty acids, particularly linoleic and alpha-linolenic acids, are crucial for maintaining skin barrier function and producing eicosanoids that regulate inflammatory processes. When these fatty acids are deficient, the skin's integrity becomes compromised, leading to increased transepidermal water loss and inflammation.

According to the ESPEN guidelines on parenteral nutrition, the nutritional requirements in patients on HPN should be based on a formal nutritional assessment, including disease-specific needs and factors such as medical condition, nutritional status, activity level, and fluid restrictions and organ function 1. The prescription should supply the complete nutrient range if required and should be easily managed at home.

Key points to consider in this scenario include:

  • Essential fatty acid deficiency is a well-documented complication of prolonged TPN without adequate lipid supplementation
  • The rash typically develops after 2-4 weeks of fat-free TPN
  • Treatment involves adding lipid emulsions to the TPN regimen, which can improve skin manifestations within 1-2 weeks
  • Nutritional requirements should be based on a formal nutritional assessment, including disease-specific needs and other factors.

In terms of morbidity, mortality, and quality of life, it is crucial to recognize and treat essential fatty acid deficiency promptly to prevent progression to generalized dermatitis and other complications. This can be achieved by adding lipid emulsions to the TPN regimen and monitoring the patient's response to treatment.

From the Research

Eczematoid Rash at Intertriginous Areas with Prolonged Total Parenteral Nutrition

  • The condition is caused by a deficiency of a specific nutrient, which is essential for maintaining healthy skin and immune function.
  • The correct answer is:
    • (a) zinc deficiency
  • This is supported by several studies, including 2, 3, 4, 5, and 6, which demonstrate the importance of zinc supplementation in patients receiving total parenteral nutrition.
  • Key findings from these studies include:
    • Zinc deficiency can cause dermatitis and skin lesions, particularly in intertriginous areas 2, 3, 4.
    • Patients receiving total parenteral nutrition are at risk of zinc deficiency due to inadequate supplementation or shortages of trace minerals 4, 6.
    • Zinc supplementation is essential for preventing and treating zinc deficiency in patients receiving total parenteral nutrition 2, 3, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical zinc deficiency in total parenteral nutrition: zinc supplementation.

JPEN. Journal of parenteral and enteral nutrition, 1983

Research

Zinc and total parenteral nutrition.

Southern medical journal, 1977

Research

Zinc: physiology, deficiency, and parenteral nutrition.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.